159 related articles for article (PubMed ID: 17292994)
21. Metabolic syndrome and ALA54THR polymorphism of fatty acid-binding protein 2 in obese patients.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R
Metabolism; 2011 May; 60(5):664-8. PubMed ID: 20723947
[TBL] [Abstract][Full Text] [Related]
22. [Study on the relationship between FABP2 Ala54Thr polymorphism and the risk of non-alcoholic fatty liver diseases].
Peng X; Zhang L; Wang Q; Cui X
Wei Sheng Yan Jiu; 2009 Jul; 38(4):401-4. PubMed ID: 19689066
[TBL] [Abstract][Full Text] [Related]
23. 1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population.
Meshkani R; Taghikhani M; Mosapour A; Larijani B; Khatami S; Khoshbin E; Ahmadvand D; Saeidi P; Maleki A; Yavari K; Nasoohi N; Adeli K
Arch Med Res; 2007 Jul; 38(5):556-62. PubMed ID: 17560463
[TBL] [Abstract][Full Text] [Related]
24. Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men.
Yamada K; Yuan X; Ishiyama S; Koyama K; Ichikawa F; Koyanagi A; Koyama W; Nonaka K
Diabetologia; 1997 Jun; 40(6):706-10. PubMed ID: 9222651
[TBL] [Abstract][Full Text] [Related]
25. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease.
Erkkilä AT; Lindi V; Lehto S; Pyörälä K; Laakso M; Uusitupa MI
Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):53-9. PubMed ID: 12189904
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism Ala54Thr of fatty acid-binding protein 2: Allelic frequencies and influence on cardiovascular risk factors in a multicenter study of Castilla y Leon.
de Luis DA; Ballesteros M; Ruiz E; Cordero M; Muñoz C; Penacho MA; Iglesias P; Lopez Guzman A; Maldonado A; San Martin L; Puigdevall V; Romero E; Gonzalez Sagrado M; Izaola O; Conde R
Ann Nutr Metab; 2010; 57(3-4):163-8. PubMed ID: 21079390
[TBL] [Abstract][Full Text] [Related]
27. FABP2 gene polymorphism and metabolic syndrome in elderly people of croatian descent.
Turkovic LF; Pizent A; Dodig S; Pavlovic M; Pasalic D
Biochem Med (Zagreb); 2012; 22(2):217-24. PubMed ID: 22838187
[TBL] [Abstract][Full Text] [Related]
28. The Ala54Thr polymorphism of the FABP2 gene influences the postprandial fatty acids in patients with type 2 diabetes.
Almeida JC; Gross JL; Canani LH; Zelmanovitz T; Perassolo MS; Azevedo MJ
J Clin Endocrinol Metab; 2010 Aug; 95(8):3909-17. PubMed ID: 20484485
[TBL] [Abstract][Full Text] [Related]
29. Association of the FABP2 Ala54Thr polymorphism with type 2 diabetes, obesity, and metabolic syndrome: a population-based case-control study and a systematic meta-analysis.
Liu Y; Wu G; Han L; Zhao K; Qu Y; Xu A; Huang Q
Genet Mol Res; 2015 Feb; 14(1):1155-68. PubMed ID: 25730055
[TBL] [Abstract][Full Text] [Related]
30. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes.
Tamai M; Furuta H; Kawashima H; Doi A; Hamanishi T; Shimomura H; Sakagashira S; Nishi M; Sasaki H; Sanke T; Nanjo K
Diabetes Res Clin Pract; 2006 Feb; 71(2):140-5. PubMed ID: 15990193
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index.
Zhao T; Zhao J; Lv J; Nzekebaloudou M
Nutr Metab Cardiovasc Dis; 2011 Oct; 21(10):823-9. PubMed ID: 20621703
[TBL] [Abstract][Full Text] [Related]
32. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability.
Helwig U; Rubin D; Klapper M; Li Y; Nothnagel M; Fölsch UR; Döring F; Schreiber S; Schrezenmeir J
Metabolism; 2007 Jun; 56(6):723-31. PubMed ID: 17512303
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
[TBL] [Abstract][Full Text] [Related]
34. Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population.
Duarte NL; Colagiuri S; Palu T; Wang XL; Wilcken DE
Mol Genet Metab; 2003 Jul; 79(3):183-8. PubMed ID: 12855223
[TBL] [Abstract][Full Text] [Related]
35. The Ala54Thr Polymorphism of the Fatty Acid Binding Protein 2 Gene Modulates HDL Cholesterol in Mexican-Americans with Type 2 Diabetes.
Salto LM; Bu L; Beeson WL; Firek A; Cordero-MacIntyre Z; De Leon M
Int J Environ Res Public Health; 2015 Dec; 13(1):ijerph13010052. PubMed ID: 26703680
[TBL] [Abstract][Full Text] [Related]
36. Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: The Hisayama Study.
Doi Y; Kubo M; Ninomiya T; Yonemoto K; Iwase M; Arima H; Hata J; Tanizaki Y; Iida M; Kiyohara Y
Diabetes; 2007 Nov; 56(11):2829-33. PubMed ID: 17965318
[TBL] [Abstract][Full Text] [Related]
37. Association of angiotensin-converting enzyme (ACE) and fatty acid binding protein 2 (FABP2) genes polymorphism with type 2 diabetes mellitus in Northern India.
Raza ST; Fatima J; Ahmed F; Abbas S; Zaidi ZH; Singh S; Mahdi F
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):572-9. PubMed ID: 23468166
[TBL] [Abstract][Full Text] [Related]
38. Effects of FABP2 Ala54Thr gene polymorphism on obesity and metabolic syndrome in middle-aged Korean women with abdominal obesity.
Han TK; So WY
Cent Eur J Public Health; 2019 Mar; 27(1):37-43. PubMed ID: 30927395
[TBL] [Abstract][Full Text] [Related]
39. Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes.
Li LL; Kang XL; Ran XJ; Wang Y; Wang CH; Huang L; Ren J; Luo X; Mao XM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1287-90. PubMed ID: 17973869
[TBL] [Abstract][Full Text] [Related]
40. The Ala45Thr polymorphism of BETA2/NeuroD1 gene and susceptibility to type 2 diabetes mellitus in a Polish population.
Malecki MT; Cyganek K; Klupa T; Sieradzki J
Acta Diabetol; 2003 Jun; 40(2):109-11. PubMed ID: 12861411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
